{"id":343839,"date":"2022-04-23T19:50:04","date_gmt":"2022-04-23T17:50:04","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=343839"},"modified":"2022-04-23T19:50:04","modified_gmt":"2022-04-23T17:50:04","slug":"fajzer-povlaci-neke-serije-ljekova-za-krvni-pritisak","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2022\/04\/23\/fajzer-povlaci-neke-serije-ljekova-za-krvni-pritisak\/","title":{"rendered":"Fajzer povla\u010di neke serije ljekova za krvni pritisak"},"content":{"rendered":"<p>Proizvo\u0111a\u010d ljekova je rekao da nije upoznat ni sa kakvim izvje\u0161tajima o ne\u017eeljenim doga\u0111ajima u vezi sa povu\u010denim serijama, koje su distribuirane u SAD i Portoriku od decembra 2019. do aprila 2022.<\/p>\n<p>Fajzer Kanada je tako\u0111e opozvao sve serije od tri doze Accuprila nakon \u0161to je otkrio da je ista ne\u010dista supstanca iznad prihvatljivog nivoa, prenosi N1.<\/p>\n<p>Iz ove kompanije je re\u010deno da ne postoji neposredan rizik za pacijente koji uzimaju ovaj lijek, u kom je prona\u0111en agens, nitrozamin.<\/p>\n<p>Nitrozamini su uobi\u010dajeni u vodi i hrani, ali izlo\u017eenost iznad prihvatljivih nivoa tokom du\u017eeg vremenskog perioda mo\u017ee povec\u0301ati rizik od karcinoma.<\/p>\n<p>Fajzer je pro\u0161log mjeseca tako\u0111e opozvao neke serije drugog lijeka za krvni pritisak Accuretic i dvije odobrene jeftinije verzije zbog prisustva moguc\u0301eg kancerogena.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kompanija Fajzer je saop\u0161tila da povla\u010di pet serija tableta za krvni pritisak Accupril nakon \u0161to je prona\u0161la povi\u0161ene nivoe potencijalnog agensa u lijeku koji izaziva karcinom.<\/p>\n","protected":false},"author":1,"featured_media":318964,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-343839","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/343839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=343839"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/343839\/revisions"}],"predecessor-version":[{"id":343840,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/343839\/revisions\/343840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/318964"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=343839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=343839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=343839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}